Exploration of integrative Chinese and western medicine diagnosis and treatment on autoimmune hepatitis combined with metabolism-related steatohepatopathy

GOU Yue; XING Feng; LIU Chenghai

doi:10.16025/j.1674-1307.2024.06.005

您当前的位置：

首页 >

文章列表页 >

Exploration of integrative Chinese and western medicine diagnosis and treatment on autoimmune hepatitis combined with metabolism-related steatohepatopathy

更新时间：2024-07-29

- Exploration of integrative Chinese and western medicine diagnosis and treatment on autoimmune hepatitis combined with metabolism-related steatohepatopathy
- Beijing Journal of Traditional Chinese Medicine Vol. 43, Issue 6, Pages: 600-605(2024)
- 作者机构：
  
  上海中医药大学附属曙光医院肝病研究所，上海 201203
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2024.06.005
  CLC：
- Published：25 June 2024，
  
  Received：10 May 2024，
- 稿件说明：
扫描看全文
苟悦，邢枫，刘成海.自身免疫性肝炎合并代谢相关脂肪性肝病的中西医结合诊治探讨［J］.北京中医药，2024，43（6）：600-605.

GOU Yue,XING Feng,LIU Chenghai.Exploration of integrative Chinese and western medicine diagnosis and treatment on autoimmune hepatitis combined with metabolism-related steatohepatopathy[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(06):600-605.
苟悦，邢枫，刘成海.自身免疫性肝炎合并代谢相关脂肪性肝病的中西医结合诊治探讨［J］.北京中医药，2024，43（6）：600-605. DOI： 10.16025/j.1674-1307.2024.06.005.

GOU Yue,XING Feng,LIU Chenghai.Exploration of integrative Chinese and western medicine diagnosis and treatment on autoimmune hepatitis combined with metabolism-related steatohepatopathy[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(06):600-605. DOI： 10.16025/j.1674-1307.2024.06.005.

摘要

代谢相关脂肪性肝病（metabolic dysfunction-associated steatotic liver disease，MASLD）的患病率居肝病之首，自身免疫性肝炎（autoimmune hepatitis， AIH）与MASLD合并致病临床常见。这2种肝病虽临床表现相似，但病理机制与诊疗均有显著区别，相兼出现后病情复杂、治疗困难，目前尚缺乏研究与诊治共识。本文首先分析AIH合并MASLD现有的诊疗难题，归纳二者的主要鉴别要点，初步提出AIH合并MASLD的临床诊疗流程图；继而指出AIH合并MASLD属于中医学合病范畴，其主要病机为肝郁脾虚肾亏、湿热痰浊瘀血阻滞，基本治则为疏肝健脾益肾、清热化痰活血，“党参、茯苓、白术、女贞子、枸杞子、川芎、赤芍、黄芩、薏苡仁、陈皮、半夏、浙贝母”为基础方剂，针对个体体质及病程特点辨证加减，灵活配伍以改善临床症状及患者预后。提出临床诊疗过程中应重视AIH合并MASLD这一合并症，积极开展中西医结合临床诊治研究，以改善患者预后。

Abstract

The morbidity of metabolic dysfunction-associated steatotic liver disease （MASLD） is the highest among liver diseases， and the combination of autoimmune hepatitis （AIH） and MASLD is commonly seen clinically. Although the clinical manifestations of these two liver diseases are similar， there are significant differences in pathologic mechanism and diagnosis and treatment， and there is a lack of consensus on the research and diagnosis and treatment of these two liver diseases because of the complexity of the condition and the difficulty of the treatment after the concurrency. This paper firstly analyzes the existing difficulties in diagnosis and treatment of AIH combined with MASLD， summarizes the main identification points of the two， and initially put forward the clinical diagnosis and treatment flowchart； then， it points out that AIH combined with MASLD belongs to the category of combined diseases in Chinese medicine， and the main pathogenesis is depression of liver， deficiency of spleen and kidney， obstruction of dampness， heat， phlegm， stasis and blood stagnation， and the basic treatment principles are to dredge liver， strengthen the spleen and benefit the kidney， and to clear away heat and resolve phlegm and activate blood circulation. Codonopsis， Poria， Atractylodes macrocephala， Ligustri lucidi fructus， Lycii fructus， Chuanxiong rhizome， Paeoniae radix rubra， Scutellariae radix， Coicis semen， Citri reticulatae pericarpium， Pinelliae rhizome， Fritillariae thunbergii bulbus are used as the basic formula， and it is tailored to the characteristics of the individual's physique and the course of the disease， and can be flexibly combined with the formula to improve the clinical symptoms and the patient's prognosis. Finally， it is suggested that in the clinical diagnosis and treatment，AIH combined with MASLD should be emphasized， and the clinical research on diagnosis and treatment on AIH combined with MASLD should be actively carried out so as to improve patients' prognosis.

关键词

自身免疫性肝炎代谢相关脂肪性肝病合并症诊断治疗

Keywords

Autoimmune hepatitismetabolic dysfunction-associated steatotic liver diseasecomplicationdiagnosistreatment

references

YUN B, AHN SH, OH J, et al. Effect of metabolic dysfunction-associated fatty liver disease on liver cancer risk in a population with chronic hepatitis B virus infection: A nationwide study[J]. Hepatol Res, 2022,52(12):975-984.

马雄, 王绮夏, 肖潇, 等. 自身免疫性肝炎诊断和治疗指南（2021）[J]. 临床肝胆病杂志, 2022, 38(1): 42-49.

CHOI H, BROUWER WP, ZANJIR W, et al. Nonalcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B[J]. Hepatology, 2020,71(2):539-548.

DALEKOS GN, GATSELIS NK, ZACHOU K, et al. NAFLD and autoimmune hepatitis: Do not judge a book by its cover[J]. Eur J Intern Med， 2020，75:1-9.

孙晶晶, 陶艳艳, 王清兰,等. 滋阴清热方治疗绝经后女性非酒精性脂肪性肝病的临床疗效观察[J]. 临床肝胆病杂志,2012,28(3):179-182.

WANG QX, JIANG WJ, MIAO Q, et al. Clinical and histological features of autoantibody-negative autoimmune hepatitis in Chinese patients: a single center experience[J]. J Dig Dis, 2013,14(4):175-180.

TAKAHASHI A, ABE K, OHIRA H. Nonalcoholic steatohepatitis-autoimmune hepatitis overlap[M]. Autoimmune Liver Diseases， 2014：127-136.

VERSINI M, JEANDEL PY, ROSENTHAL E, et al. Obesity in autoimmune diseases: not a passive bystander[J]. Autoimmun Rev， 2014，13(9):981-1000.

TARANTINO G, FINELLI C. Pathogenesis of hepatic steatosis: the link between hypercortisolism and non-alcoholic fatty liver disease[J]. World J Gastroenterol, 2013,19(40):6735-6743.

MüLLER P, MESSMER M, BAYER M, et al. Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model[J]. J Autoimmun, 2016,69:51-58.

TAN CK, HO D, WANG LM, et al. Drug-induced autoimmune hepatitis: A minireview[J]. World J Gastroenterol, 2022,28(24):2654-2666.

GRAZIADEI IW, OBERMOSER GE, SEPP NT, et al. Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis[J]. Lupus, 2003,12(5):409-412.

MATSUMOTO T, YAMASAKI S, ARAKAWA A, et al. Exposure to a high total dosage of glucocorticoids produces non-alcoholic steatohepatits[J]. Pathol Int, 2007,57(6):388-389.

GABER Y, ABDALLAH M, SALAMA A, et al. Metabolic-associated fatty liver disease and autoimmune hepatitis: an overlooked interaction[J]. Expert Rev Gastroenterol Hepatol, 2021,15(10):1181-1189.

WEILER-NORMANN C, LOHSE AW. Nonalcoholic fatty liver disease in patients with autoimmune hepatitis: further reason for teeth GNASHing[J].Dig Dis Sci, 2016,61(9):2462-2464.

MACK CL, ADAMS D, ASSIS DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases[J]. Hepatology, 2020,72(2):671-722.

PAPE S, GEVERS T, BELIAS M, et al. Predniso(lo)ne dosage and chance of remission in patients with autoimmune hepatitis[J]. Clin Gastroenterol Hepatol, 2019,17(10):2068-2075.e2.

孙韬, 卢秉久. 中医辨治自身免疫性肝炎浅析[J]. 实用中医内科杂志, 2011, 25(5): 77-78.

倪瑶, 刘明坤, 张婷婷,等. 吕文良教授从“调和气血”论治自身免疫性肝炎[J]. 辽宁中医药大学学报,2017,19(10):122-124.

杨苏纳, 陈斌. 从肝、脾、肾探讨自身免疫性肝炎中医病机理论[J]. 亚太传统医药,2021,17(4):217-219.

钟郁萱. 基于数据挖掘的刘汶教授治疗非酒精性脂肪性肝病回顾性研究[D].北京:北京中医药大学,2021.

中华中医药学会.中医内科常见病诊疗指南-西医疾病部分[M]. 北京:中国中医药出版社,2008:47-49.

钟启华, 王融冰, 李斌,等. 247例自身免疫性肝炎患者中医体质分布及衍变规律分析研究[J]. 北京中医药,2019,38(6):536-540.

中华中医药学会脾胃病分会. 非酒精性脂肪性肝病中医诊疗指南(基层医生版)[J]. 中西医结合肝病杂志,2019,29(5):后插3-6.

李会杰, 郑五州, 郭亚南,等. 从虚郁痰瘀论治糖尿病合并非酒精性脂肪肝效果观察[J]. 北京中医药,2023,42(2):151-155.

刘福栋,庞博,吕文良,等.从气虚络瘀角度探讨肝纤维化氧化应激机制[J].北京中医药,2022,41(6):634-636.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Pathogenesis and treatment of viral myocarditis atrial fibrillation in Chinese medicine

Research on the constitution distribution and evolution law in 247 cases of autoimmune hepatitis

Analysis of prescriptions for prevention and treatment of novel coronavirus pneumonia made by national Chinese medicine masters

Related Author

CHU Yuguang

HU Yuanhui

YUAN Chenlu

ZHONG Qi-hua

WANG Rong-bing

LI Bin

WANG Xian-bo

ZHOU Gui-qin

Related Institution

Department of Cardiovascular Medicine， Guang'anmen Hospital，China Academy of Traditional Chinese Medial Sciences

Department of Infection,Shangluo Central Hospital of Shannxi Province

Center for Integrative Medicine,Beijing Ditan Hospital Affiliated to the Capital Medical University

陕西省商洛市中心医院感染科首都医科大学附属北京地坛医院中西医结合中心

Beijing University of Chinese Medicine

⁰